Get the Stockscreener App
85.91
0.97%
-0.92
Vaxcyte Inc stock is traded at $85.91, with a volume of 961.50K.
It is down -0.97% in the last 24 hours and down -25.55% over the past month.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.
See More
Previous Close:
$86.83
Open:
$86.5
24h Volume:
961.50K
Relative Volume:
0.89
Market Cap:
$10.71B
Revenue:
-
Net Income/Loss:
$-507.65M
P/E Ratio:
-22.16
EPS:
-3.876
Net Cash Flow:
$-616.24M
1W Performance:
-17.03%
1M Performance:
-25.55%
6M Performance:
+15.31%
1Y Performance:
+67.10%
1-Day Range:
$84.52
$87.32
1-Week Range:
$84.52
$103.30
52-Week Range:
$48.24
$121.06
Vaxcyte Inc Stock (PCVX) Company Profile
Name
Vaxcyte Inc
Sector
Industry
Phone
650-837-0111
Address
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA
Compare PCVX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| PCVX | 85.92 | 10.71B | 0 | -507.65M | -616.24M | -3.876 |
| VRTX | 467.17 | 119.83B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 760.51 | 83.28B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 565.09 | 33.74B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 230.39 | 30.38B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.56 | 24.08B | 3.30B | -501.07M | 1.03B | 11.54 |
Vaxcyte Inc Stock (PCVX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-07-23 | Initiated | Mizuho | Buy |
| Apr-18-23 | Initiated | TD Cowen | Outperform |
| Jan-03-23 | Reiterated | Needham | Buy |
| Dec-15-22 | Initiated | Guggenheim | Buy |
| Nov-17-22 | Initiated | BTIG Research | Buy |
| Dec-29-21 | Resumed | Jefferies | Buy |
| Jun-24-21 | Resumed | Jefferies | Buy |
| Jul-07-20 | Initiated | BofA Securities | Buy |
| Jul-07-20 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-07-20 | Initiated | Needham | Buy |
View All
Vaxcyte Inc Stock (PCVX) Latest News
Victory Capital Management Inc. Has $29.14 Million Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte, Inc. (NASDAQ:PCVX) Given Average Recommendation of "Buy" by Analysts - MarketBeat
Curi RMB Capital LLC Purchases New Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Los Angeles Capital Management LLC Takes $1.02 Million Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte (NASDAQ:PCVX) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat
RA Capital Management, L.P. Increases Stake in Vaxcyte Inc - GuruFocus.com
Janus Henderson Group PLC's Strategic Acquisition of Vaxcyte Inc Shares - GuruFocus.com
Long Term Trading Analysis for (PCVX) - Stock Traders Daily
Vaxcyte Enters Oversold Territory (PCVX) - Nasdaq
FMR LLC Adjusts Stake in Vaxcyte Inc - GuruFocus.com
Vaxcyte provides regulatory updates on VAX-31 programs - TipRanks
FDA advances Vaxcyte's pneumococcal vaccine VAX-31 By Investing.com - Investing.com Canada
FDA advances Vaxcyte's pneumococcal vaccine VAX-31 - Investing.com
Vaxcyte Provides Positive Regulatory Updates on VAX-31 Pediatric and Adult Programs - The Bakersfield Californian
Vaxcyte's VAX-31 Vaccine Secures FDA Breakthrough Status, Targets 95% Disease Coverage | PCVX Stock News - StockTitan
WCM Investment Management LLC Has $15.94 Million Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Lisanti Capital Growth LLC Purchases 13,175 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Cantor Fitzgerald Increases Earnings Estimates for Vaxcyte - MarketBeat
TimesSquare Capital Management LLC Buys New Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte, Inc. (NASDAQ:PCVX) CEO Sells $245,803.74 in Stock - MarketBeat
Vaxcyte CEO Grant Pickering sells $245,796 in company stock - Investing.com India
Vaxcyte CEO Grant Pickering sells $245,796 in company stock By Investing.com - Investing.com Australia
FY2024 EPS Estimates for Vaxcyte Raised by Leerink Partnrs - MarketBeat
We're Hopeful That Vaxcyte (NASDAQ:PCVX) Will Use Its Cash Wisely - Yahoo Finance
Vaxcyte, Inc. Navigates AI Risks Amidst Regulatory and Ethical Challenges - TipRanks
Vaxcyte's (PCVX) Overweight Rating Reaffirmed at Cantor Fitzgerald - MarketBeat
Vaxcyte's (PCVX) "Buy" Rating Reiterated at Needham & Company LLC - MarketBeat
Vaxcyte stock target lifted as analyst sees VAX-31 leading in clinical advancement - Investing.com UK
Leerink Partners reaffirms Outperform on Vaxcyte stock with bullish pipeline outlook - Investing.com UK
Decoding Vaxcyte Inc (PCVX): A Strategic SWOT Insight - GuruFocus.com
Vaxcyte Reports Progress and Strengthens Financial Position - TipRanks
Vaxcyte Inc (PCVX) Reports Q3 2024 Net Loss of $103.1 Million Am - GuruFocus.com
Vaxcyte Reports Third Quarter 2024 Financial Results and Provides Business Update - The Manila Times
Vaxcyte's VAX-31 Vaccine Shows Promise in Phase 1/2, Plans Phase 3 Amid $3.3B Cash Position | PCVX Stock News - StockTitan
Vaxcyte, Inc. (NASDAQ:PCVX) COO Jim Wassil Sells 8,000 Shares - MarketBeat
Vaxcyte CEO Grant Pickering sells shares worth $1.6 million By Investing.com - Investing.com Australia
Vaxcyte COO Jim Wassil sells $854k in stock - Investing.com
Vaxcyte CEO Grant Pickering sells shares worth $1.6 million - Investing.com
Vaxcyte COO Jim Wassil sells $854k in stock By Investing.com - Investing.com UK
Harbor Capital Advisors Inc. Has $7.39 Million Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Should You Consider Investing in Vaxcyte (PCVX)? - Insider Monkey
Raymond James & Associates Buys 11,798 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte’s stock flat as biotech preps to complete $1.42 billion stock offering - MSN
Vaxcyte (NASDAQ:PCVX) Trading Down 5.9%Time to Sell? - MarketBeat
China Universal Asset Management Co. Ltd. Grows Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Novo Holdings A S Has $85.70 Million Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Creative Planning Buys 10,245 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte stock holds $160 target with Buy rating from BTIG By Investing.com - Investing.com Canada
Moody Aldrich Partners LLC Trims Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
How To Trade (PCVX) - Stock Traders Daily
Vaxcyte, Inc. (NASDAQ:PCVX) Receives $147.50 Average Price Target from Brokerages - MarketBeat
Vaxcyte Inc Stock (PCVX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Vaxcyte Inc Stock (PCVX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| PICKERING GRANT | CHIEF EXECUTIVE OFFICER |
Nov 07 '24 |
Sale |
103.89 |
2,366 |
245,796 |
137,398 |
3.39%
0.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):